Immunogenicity assay: Anti-drug antibody
Screening for the presence of anti-drug antibodies (ADAs) in test populations is key to ensuring drug safety and efficacy. In large molecule drugs, antibody reactions can have a wide and unpredictable range of effects, including life-threatening immune responses. Performing ADA assays can give a clear picture of possible ADAs and inform further development.